Association between a genome-wide association study-identified locus and the risk of lung cancer in Japanese population

Journal of Thoracic Oncology

Volumn 7, Issue 5, 2012, Pages 790-798

  Ito, Hidemi ^a   McKay, James D ^a,b   Hosono, Satoyo ^a   Hida, Toyoaki ^a   Yatabe, Yasushi ^a   Mitsudomi, Tetsuya ^a   Brennan, Paul ^b   Tanaka, Hideo ^a,c   Matsuo, Keitaro ^a,c  

^a AICHI CANCER CENTER HOSPITAL   (Japan)

^b International Agency for Research on Cancer   (Japan)

^c NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

15q25; 5p15; Genetic susceptibility; Lung cancer; Smoking

Indexed keywords

ADULT; AGED; ALLELE; CANCER RISK; CHROMOSOME; CONTROLLED STUDY; FEMALE; GENE LOCUS; GENETIC ASSOCIATION; GENETIC VARIABILITY; HUMAN; JAPANESE; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REVIEW; SMOKING;

EID: 84862147121     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0b013e3182475028     Document Type: Article

References (51)

1. Thomas D. Gene-environment-wide association studies: emerging approaches. Nat Rev Genet 2010;11:259-272.
2. Truong T, Hung RJ, Amos CI,. et al. Replication of lung cancer susceptibility loci at chromosomes 15q25, 5p15, and 6p21: a pooled analysis from the International Lung Cancer Consortium. J Natl Cancer Inst 2010;102:959-971.
3. Thorgeirsson TE, Geller F, Sulem P,. et al. A variant associated with nicotine dependence, lung cancer and peripheral arterial disease. Nature 2008;452:638-642.
4. Hung RJ, Christiani DC, Risch A,. et al. International Lung Cancer Consortium: pooled analysis of sequence variants in DNA repair and cell cycle pathways. Cancer Epidemiol Biomarkers Prev 2008;17:3081-3089.
5. Amos CI, Wu X, Broderick P,. et al. Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1. Nat Genet 2008;40:616-622.
6. Sun S, Schiller JH, Gazdar AF. Lung cancer in never smokers-a different disease. Nat Rev Cancer 2007;7:778-790.
7. The International HapMap Project. Nature 2003;426:789-796.
8. Berrettini W, Yuan X, Tozzi F,. et al. Alpha-5/alpha-3 nicotinic receptor subunit alleles increase risk for heavy smoking. Mol Psychiatry 2008;13:368-373.
9. Caporaso N, Gu F, Chatterjee N,. et al. Genome-wide and candidate gene association study of cigarette smoking behaviors. PLoS One 2009;4:e4653.
10. Saccone NL, Wang JC, Breslau N,. et al. The CHRNA5-CHRNA3-CHRNB4 nicotinic receptor subunit gene cluster affects risk for nicotine dependence in African-Americans and in European-Americans. Cancer Res 2009;69:6848-6856.
11. Stevens VL, Bierut LJ, Talbot JT,. et al. Nicotinic receptor gene variants influence susceptibility to heavy smoking. Cancer Epidemiol Biomarkers Prev 2008;17:3517-3525.
12. Weiss RB, Baker TB, Cannon DS,. et al. A candidate gene approach identifies the CHRNA5-A3-B4 region as a risk factor for age-dependent nicotine addiction. PLoS Genet 2008;4:e1000125.
13. Saccone SF, Hinrichs AL, Saccone NL,. et al. Cholinergic nicotinic receptor genes implicated in a nicotine dependence association study targeting 348 candidate genes with 3713 SNPs. Hum Mol Genet 2007;16:36-49.
14. Spitz MR, Amos CI, Dong Q,. et al. The CHRNA5-A3 region on chromosome 15q24-25.1 is a risk factor both for nicotine dependence and for lung cancer. J Natl Cancer Inst 2008;100:1552-1556.
15. Thorgeirsson TE, Gudbjartsson DF, Surakka I,. et al. Sequence variants at CHRNB3-CHRNA6 and CYP2A6 affect smoking behavior. Nat Genet 2010;42:448-453.
16. Saccone NL, Culverhouse RC, Schwantes-An TH,. et al. Multiple independent loci at chromosome 15q25.1 affect smoking quantity: a meta-analysis and comparison with lung cancer and COPD. PLoS Genet 2010;6:e1001053.
17. Liu JZ, Tozzi F, Waterworth DM,. et al. Meta-analysis and imputation refines the association of 15q25 with smoking quantity. Nat Genet 2010;42:436-440.
18. Rafnar T, Sulem P, Stacey SN,. et al. Sequence variants at the TERT-CLPTM1L locus associate with many cancer types. Nat Genet 2009;41:221-227.
19. Wang Y, Broderick P, Webb E,. et al. Common 5p15.33 and 6p21.33 variants influence lung cancer risk. Nat Genet 2008;40:1407-1409.
20. McKay JD, Hung RJ, Gaborieau V,. et al. Lung cancer susceptibility locus at 5p15.33. Nat Genet 2008;40:1404-1406.
21. Hsiung CA, Lan Q, Hong YC,. et al. The 5p15.33 locus is associated with risk of lung adenocarcinoma in never-smoking females in Asia. PLoS Genet 2010;6:e1001051.
22. Landi MT, Chatterjee N, Yu K,. et al. A genome-wide association study of lung cancer identifies a region of chromosome 5p15 associated with risk for adenocarcinoma. Am J Hum Genet 2009;85:679-691.
23. Shigematsu H, Lin L, Takahashi T,. et al. Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers. J Natl Cancer Inst 2005;97:339-346.
24. Matsuo K, Ito H, Yatabe Y,. et al. Risk factors differ for non-small-cell lung cancers with and without EGFR mutation: assessment of smoking and sex by a case-control study in Japanese. Cancer Sci 2007;98:96-101.
25. Hamajima N, Matsuo K, Saito T,. et al. Gene-environment interactions and polymorphism studies of cancer risk in the hospital-based epidemiologic research program at Aichi Cancer Center II (HERPACC-II). Asian Pac J Cancer Prev 2001;2:99-107.
26. Tajima K, Hirose K, Inoue M,. et al. A model of practical cancer prevention for out-patients visiting a hospital: the hospital-based epidemiologic research program at Aichi Cancer Center (HERPACC). Asian Pac J Cancer Prev 2000;1:35-47.
27. Inoue M, Tajima K, Hirose K,. et al. Epidemiological features of first-visit outpatients in Japan: comparison with general population and variation by sex, age, and season. J Clin Epidemiol 1997;50:69-77.
28. Livak KJ. Allelic discrimination using fluorogenic probes and the 5' nuclease assay. Genet Anal 1999;14:143-149.
29. Yatabe Y, Hida T, Horio Y,. et al. A rapid, sensitive assay to detect EGFR mutation in small biopsy specimens from lung cancer. J Mol Diagn 2006;8:335-341.
30. Yatabe Y, Kosaka T, Takahashi T,. et al. EGFR mutation is specific for terminal respiratory unit type adenocarcinoma. Am J Surg Pathol 2005;29:633-639.
31. Kosaka T, Yatabe Y, Endoh H,. et al. Mutations of the epidermal growth factor receptor gene in lung cancer: biological and clinical implications. Cancer Res 2004;64:8919-8923.
32. Pao W, Miller V, Zakowski M,. et al. EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib. Proc Natl Acad Sci USA 2004;101:13306-13311.
33. Minna JD. Nicotine exposure and bronchial epithelial cell nicotinic acetylcholine receptor expression in the pathogenesis of lung cancer. J Clin Invest 2003;111:31-33.
34. Improgo MR, Scofield MD, Tapper AR,. et al. From smoking to lung cancer: the CHRNA5/A3/B4 connection. Oncogene 2010;29:4874-4884.
35. Brennan P, Hainaut P, Boffetta P. Genetics of lung-cancer susceptibility. Lancet Oncol 2011;12:399-408.
36. Krais AM, Hautefeuille A, Cros MP,. et al. CHRNA5 as negative regulator of nicotine signalling in normal and cancer bronchial cells: effects on motility, migration and p63 expression. Carcinogenesis 2011;32: 1388-1395.
37. Tournier JM, Maouche K, Coraux C,. et al. alpha3alpha5beta2-Nicotinic acetylcholine receptor contributes to the wound repair of the respiratory epithelium by modulating intracellular calcium in migrating cells. Am J Pathol 2006;168:55-68.
38. Wang JC, Cruchaga C, Saccone NL,. et al. Risk for nicotine dependence and lung cancer is conferred by mRNA expression levels and amino acid change in CHRNA5. Hum Mol Genet 2009;18:3125-3135.
39. Falvella FS, Galvan A, Frullanti E,. et al. Transcription deregulation at the 15q25 locus in association with lung adenocarcinoma risk. Clin Cancer Res 2009;15:1837-1842.
40. Wu C, Hu Z, Yu D,. et al. Genetic variants on chromosome 15q25 associated with lung cancer risk in Chinese populations. Cancer Res 2009;69:5065-5072.
41. Falvella FS, Galvan A, Colombo F,. et al. Promoter polymorphisms and transcript levels of nicotinic receptor CHRNA5. J Natl Cancer Inst 2010;102:1366-1370.
42. Shiraishi K, Kohno T, Kunitoh H,. et al. Contribution of nicotine acetylcholine receptor polymorphisms to lung cancer risk in a smoking-independent manner in the Japanese. Carcinogenesis 2009;30:65-70.
43. Galvan A, Dragani TA. Nicotine dependence may link the 15q25 locus to lung cancer risk. Carcinogenesis 2010;31:331-333.
44. Jin G, Xu L, Shu Y,. et al. Common genetic variants on 5p15.33 contribute to risk of lung adenocarcinoma in a Chinese population. Carcinogenesis 2009;30:987-990.
45. Risques RA, Vaughan TL, Li X,. et al. Leukocyte telomere length predicts cancer risk in Barrett's esophagus. Cancer Epidemiol Biomarkers Prev 2007;16:2649-2655.
46. Shen J, Terry MB, Gurvich I,. et al. Short telomere length and breast cancer risk: a study in sister sets. Cancer Res 2007;67:5538-5544.
47. Wu X, Amos CI, Zhu Y,. et al. Telomere dysfunction: a potential cancer predisposition factor. J Natl Cancer Inst 2003;95:1211-1218.
48. Fernandez-Garcia I, Ortiz-de-Solorzano C, Montuenga LM. Telomeres and telomerase in lung cancer. J Thorac Oncol 2008;3:1085-1088.
49. Wu TC, Lin P, Hsu CP,. et al. Loss of telomerase activity may be a potential favorable prognostic marker in lung carcinomas. Lung Cancer 2003;41:163-169.
50. Yamamoto K, Okamoto A, Isonishi S,. et al. A novel gene, CRR9, which was up-regulated in CDDP-resistant ovarian tumor cell line, was associated with apoptosis. Biochem Biophys Res Commun 2001;280:1148-1154.
51. Zienolddiny S, Skaug V, Landvik NE,. et al. The TERT-CLPTM1L lung cancer susceptibility variant associates with higher DNA adduct formation in the lung. Carcinogenesis 2009;30:1368-1371.